SAN CLEMENTE, Calif., March 8, 2018 /PRNewswire/ -- Spinal Singularity announced that the first patient has been treated with the Connected Catheter, an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction (NLUTD). The Clinical Feasibility Study is being led by Dr. Ernest Agatstein, MD, an expert Urologist and co-founder of West Coast Urology.
Dr. Agatstein has served as a Scientific Advisor to Spinal Singularity since 2015, when the company was founded. Dr. Agatstein states, "It has been amazing to watch the Connected Catheter develop and mature over the past couple of years. What started as a simple idea being relentlessly pursued by passionate founders is now a real medical device that has the potential to radically improve the quality of life for millions of catheter users. I am honored to have treated the first patient in the US with this device and look forward to collecting more data during this study."
Derek Herrera (Founder) explains, "I have dedicated years of my life working to solve this problem and am confident that our product can truly change people's lives. With more clinical data we aim to prove the safety and efficacy of our device as we work to bring it to market."
Spinal Singularity has also obtained IRB approval to expand the study at two additional sites. Dr. Ian Lee Goldman, MD will lead efforts at the Arizona Center for Cancer Care (AZCCC) in Surprise, AZ and Dr. Sreenivas Vemulapalli, MD will be the principal investigator at Tri-Valley Urology in Murrieta, CA. Detailed information about the clinical study can be accessed on ClinicalTrials.gov at http://bit.ly/CCCFSTrial.
About Spinal Singularity Inc.
Spinal Singularity is a seed stage, venture-backed, medical device company developing products to improve the lives of patients with Spinal Injury. The company has developed the Connected Catheter, the first fully internal, smart catheter system for adult males with Urinary Retention. One Connected Catheter may replace up to 200 disposable intermittent catheters.
Spinal Singularity recently commenced Clinical Studies for the Connected Catheter in the USA. For more information, please visit the Company's website at www.spinalsingularity.com or send an email to firstname.lastname@example.org.
The Connected Catheter is currently an INVESTIGATIONAL DEVICE ONLY and Limited by Federal (or United States) law to investigational use.
105 Avenida de la Estrella #3
San Clemente, CA 92672
SOURCE Spinal Singularity